CancerFax

Explore Expert Articles, Guides, and Resources

Knowledge Chest

Browse Our Resource Library

Showing 12 of 784 resources

Anti-cancer drug Lenvatinib approved for clinical treatment of thyroid cancerNews and Updates
News and Updates

Anti-cancer drug Lenvatinib approved for clinical treatment of thyroid cancer

Susan Hau

Mar 21, 2026
2 min
Colorectal cancer NCCN guidelines 2026Treatment Guides

Colorectal cancer NCCN guidelines 2026

Dr. Nishant Mittal

Mar 15, 2026
6 min
Lifileucel is approved by the USFDA for unresectable or metastatic melanomaClinical Insights
Clinical Insights

Lifileucel is approved by the USFDA for unresectable or metastatic melanoma

Dr. Nishant Mittal

Mar 5, 2026
3 min
Strategy for cervical cancer screeningBlog
Blog

Strategy for cervical cancer screening

Sai Sree

Feb 26, 2026
5 min
Nivolumab has been approved by the FDA for use as an adjuvant treatment for urothelial carcinomaGuides
Guides

Nivolumab has been approved by the FDA for use as an adjuvant treatment for urothelial carcinoma

Susan Hau

Aug 24, 2025
4 min
Datopotamab deruxtecan-dlnk is approved by the USFDA for EGFR-mutated non-small cell lung cancerNews and Updates
News and Updates

Datopotamab deruxtecan-dlnk is approved by the USFDA for EGFR-mutated non-small cell lung cancer

Sai Sree

Aug 21, 2025
3 min
Tafasitamab-cxix is approved by the USFDA for relapsed or refractory follicular lymphomaNews and Updates
News and Updates

Tafasitamab-cxix is approved by the USFDA for relapsed or refractory follicular lymphoma

Dr. Nishant Mittal

Aug 21, 2025
4 min
 Advancing Bardet-Biedl Syndrome Treatment in China: Gene Therapy and Clinical Innovations at NCMC, ShanghaiAwareness and Education
Awareness and Education

Advancing Bardet-Biedl Syndrome Treatment in China: Gene Therapy and Clinical Innovations at NCMC, Shanghai

Dr. Nishant Mittal

Jul 3, 2025
5 min
Breakthrough Treatments for Advanced Breast Cancer in 2025

Breakthrough Treatments for Advanced Breast Cancer in 2025

Dr. Nishant Mittal

Jun 22, 2025
5 min
Mitomycin intravesical solution is approved by the USFDA for recurrent low-grade intermediate-risk non-muscle invasive bladder cancerNews and Updates
News and Updates

Mitomycin intravesical solution is approved by the USFDA for recurrent low-grade intermediate-risk non-muscle invasive bladder cancer

Dr. Nishant Mittal

Jun 19, 2025
5 min
Taletrectinib is approved by the USFDA for ROS1-positive non-small cell lung cancerNews and Updates
News and Updates

Taletrectinib is approved by the USFDA for ROS1-positive non-small cell lung cancer

Sai Sree

Jun 18, 2025
3 min
Neoadjuvant and adjuvant pembrolizumab is approved by the USFDA for resectable locally advanced head and neck squamous cell carcinomaNews and Updates
News and Updates

Neoadjuvant and adjuvant pembrolizumab is approved by the USFDA for resectable locally advanced head and neck squamous cell carcinoma

Sai Sree

Jun 18, 2025
7 min